Insights - Eloxx (ELOX) provided a Q2 business update earlier this week, and everything was on schedule. Based on enrollment at the end of June, the company remainson track to report … Continue Reading
PremiumInsights - Essa (EPIX) reported their Q2 business update this morning. The rumors were true – Phase 1 monotherapy data will be pushed from 2H 2021 to 1H 2022. … Continue Reading
PremiumInsights - Essa (EPIX) is down 50% in the last month, with really aggressive selling coming in the last 6 trading days. Since Thursday August 5th, Essa … Continue Reading
PremiumInsights - Novavax (NVAX) had their Q2 business update call yesterday after market. The company announced yet another delay in the US submission, while the rest of the world’s … Continue Reading
PremiumInsights - Jounce (JNCE) announced 2Q results today and the company is progressing well on their Phase 1 JTX-8064 (LILRB2 / ILT4) in solid tumors. Jounce completed enrollment of … Continue Reading
PremiumDigital Conferences - Transcript of Digital Conference Participants Fahar Merchant – President & Chief Executive Officer, Medicenna Mann Muhsin – Chief Medical Officer, Medicenna Elizabeth Williams – Chief … Continue Reading
Read nowInsights - The Covid delta variant is making waves, and several countries are voicing concern. Below we look at the data and determine if the high alert … Continue Reading
Premium
